LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Table 1 Correlation between LINC00673 expression and the clinicopathological features of breast cancer

Characteristics	No. (n = 80)	LINC00673 expression		P-value
Characteristics	No. (n = 80)	Low (n = 40)	High (n = 40)	P-value
Age
< 50	38	24	14	0.446
≥ 50	42	23	19
Tumor size
≤ 2 cm	31	20	11	0.024^*
> 2 cm	49	19	30
LNM
Negative	27	17	10	0.097
Positive	53	23	30
TNM stage
I-II	74	39	35	0.089
III-IV	6	1	5
ER expression
Negative	29	16	13	0.485
Positive	51	24	27
PR expression
Negative	45	23	25	0.648
Positive	32	17	15
Her-2 expression
Negative	44	24	20	0.368
Positive	36	16	20
Ki67 expression
≤ 14%	28	19	9	0.019^*
> 14%	52	21	31

ISSN: 1756-9966